Pulmonary function remained stable -- and in some ways improved -- among patients with sickle cell disease (SCD) who ...

Discover new insights into the effects of haematopoietic cell transplant on pulmonary function in adults with sickle cell ...

Behçet's disease (BD) is a systemic large-vessel vasculitis characterized by a wide clinical spectrum including recurrent oral and genital ulcerations, uveitis, and vascular, neurological ...

The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient ...

Anti-Viral Central Memory CD8 Veto Cells is under clinical development by Cell Source and currently in Phase II for Sickle Cell Disease.

Reduced-intensity conditioning regimes for HSCT candidates have similar short-term outcomes as HSCT candidates receiving myeloablative conditioning. Partial HLA-matched cord blood is a viable stem ...

However, the patient was pending allo-HSCT with BU/FLU/Cy/ATG as the myeloablative conditioning regimen for the second time, accompanied by a large amount of transfusion and probable GVHD. Despite the ...

He is also working to reduce toxicities and maximize the cancer-killing powers of transplanted immune cells. One of Dr. Storb’s major scientific contributions is the non-myeloablative transplant.

Patients with severe internal organ involvement were excluded (table 1). The first RCT was the American Scleroderma Stem cell versus Immune Suppression Trial (ASSIST), a phase II trial comparing ...

The authors present a case of acyclovir-resistant HSV reactivation in a 26-year-old woman 7 days post T-deplete sibling allograft on a background of combined cyclophosphamide and total body ...